Dashboard
Weak Long Term Fundamental Strength with a -48.12% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 4.62% signifying low profitability per unit of shareholders funds
The company has declared Negative results for the last 3 consecutive quarters
With ROE of 1.9, it has a Very Expensive valuation with a 0.5 Price to Book Value
Falling Participation by Institutional Investors
Stock DNA
Commodity Chemicals
INR 126 Cr (Micro Cap)
25.00
42
0.00%
-0.11
2.27%
0.47
Total Returns (Price + Dividend) 
Latest dividend: 7 per share ex-dividend date: Jul-23-2024
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
29-May-2026 | Source : BSEIn compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of notice published on 29th May 2026 in respect of transfer of Equity Shares of the Company to the Investor Education and Protection Fund in accordance with the provisions of Section 124(6) of the Companies Act 2013 read with the Investor Education and Protection Fund Authority (Accounting Audit Transfer and Refund) Rules 2016 as amended from time to time in Business Standards (English Language) nationwide circulation and Business Standards New Delhi Edition- NCR in Hindi language.
Announcement under Regulation 30 (LODR)-Newspaper Publication
29-May-2026 | Source : BSENewspaper Advertisement regarding opening of Special Window for re-lodgement of transfer request of physical shares
Compliances-Reg.24(A)-Annual Secretarial Compliance
27-May-2026 | Source : BSEPursuant to the Regulation 24A of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are forwarding herewith the Annual Secretarial Compliance Report for the financial year 2025-26.
Corporate Actions 
No Upcoming Board Meetings
AG Ventures Ltd has declared 70% dividend, ex-date: 23 Jul 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (2.67%)
Held by 3 FIIs (0.27%)
Cosmopolitan Investments Private Limited (25.59%)
Hdfc Large And Mid Cap Fund (2.62%)
36.96%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is -9.38% vs 18.88% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -103.41% vs -94.36% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.12% vs 29.01% in Sep 2024
Growth in half year ended Sep 2025 is -56.46% vs -70.78% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 1.93% vs 39.73% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -46.82% vs -71.18% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -0.99% vs 33.40% in Mar 2025
YoY Growth in year ended Mar 2026 is -51.58% vs -78.84% in Mar 2025